Pāriet uz galveno navigāciju Pāriet uz meklēšanu Pāriet uz galveno saturu

Interventions to reduce colonisation and transmission of antimicrobial-resistant bacteria in intensive care units: An interrupted time series study and cluster randomised trial

  • Lennie P.G. Derde*
  • , Ben S. Cooper
  • , Herman Goossens
  • , Surbhi Malhotra-Kumar
  • , Rob J.L. Willems
  • , Marek Gniadkowski
  • , Waleria Hryniewicz
  • , Joanna Empel
  • , Mirjam J.D. Dautzenberg
  • , Djillali Annane
  • , Irene Aragão
  • , Annie Chalfine
  • , Uga Dumpis
  • , Francisco Esteves
  • , Helen Giamarellou
  • , Igor Muzlovic
  • , Giuseppe Nardi
  • , George L. Petrikkos
  • , Viktorija Tomic
  • , Antonio Torres Martí
  • Pascal Stammet, Christian Brun-Buisson, Marc J.M. Bonten
*Šī darba korespondējošais autors
  • Utrecht University
  • University of Oxford
  • University of Antwerp
  • National Medicines Institute, Warsaw
  • Hôpital Raymond Poincaré
  • University Hospital Center of Santo António
  • Hôpital Saint-Joseph
  • Paula Stradina Clinical University Hospital
  • Centro Hospitalar Trás-os-Montes e Alto Douro
  • National and Kapodistrian University of Athens
  • University Medical Centre
  • San Camillo Hospital
  • University Clinic of Respiratory and Allergic Diseases
  • University of Barcelona
  • Center Hospitalier de Luxembourg
  • Université Paris Cité

Zinātniskās darbības rezultāts: Devums žurnālam › Zinātniskais raksts (žurnālā) › koleģiāli recenzēts

303 Atsauces (Scopus)

Kopsavilkums

Background: Intensive care units (ICUs) are high-risk areas for transmission of antimicrobial-resistant bacteria, but no controlled study has tested the effect of rapid screening and isolation of carriers on transmission in settings with best-standard precautions. We assessed interventions to reduce colonisation and transmission of antimicrobial-resistant bacteria in European ICUs. Methods: We did this study in three phases at 13 ICUs. After a 6 month baseline period (phase 1), we did an interrupted time series study of universal chlorhexidine body-washing combined with hand hygiene improvement for 6 months (phase 2), followed by a 12-15 month cluster randomised trial (phase 3). ICUs were randomly assigned by computer generated randomisation schedule to either conventional screening (chromogenic screening for meticillin-resistant Staphylococcus aureus [MRSA] and vancomycin-resistant enterococci [VRE]) or rapid screening (PCR testing for MRSA and VRE and chromogenic screening for highly resistant Enterobacteriaceae [HRE]); with contact precautions for identified carriers. The primary outcome was acquisition of resistant bacteria per 100 patient-days at risk, for which we calculated step changes and changes in trends after the introduction of each intervention. We assessed acquisition by microbiological surveillance and analysed it with a multilevel Poisson segmented regression model. We compared screening groups with a likelihood ratio test that combined step changes and changes to trend. This study is registered with ClinicalTrials.gov, number NCT00976638. Findings: Seven ICUs were assigned to rapid screening and six to conventional screening. Mean hand hygiene compliance improved from 52% in phase 1 to 69% in phase 2, and 77% in phase 3. Median proportions of patients receiving chlorhexidine body-washing increased from 0% to 100% at the start of phase 2. For trends in acquisition of antimicrobial-resistant bacteria, weekly incidence rate ratio (IRR) was 0·976 (0·954-0·999) for phase 2 and 1·015 (0·998-1·032) for phase 3. For step changes, weekly IRR was 0·955 (0·676-1·348) for phase 2 and 0·634 (0·349-1·153) for phase 3. The decrease in trend in phase 2 was largely caused by changes in acquisition of MRSA (weekly IRR 0·925, 95% CI 0·890-0·962). Acquisition was lower in the conventional screening group than in the rapid screening group, but did not differ significantly (p=0·06). Interpretation: Improved hand hygiene plus unit-wide chlorhexidine body-washing reduced acquisition of antimicrobial-resistant bacteria, particularly MRSA. In the context of a sustained high level of compliance to hand hygiene and chlorhexidine bathings, screening and isolation of carriers do not reduce acquisition rates of multidrug-resistant bacteria, whether or not screening is done with rapid testing or conventional testing. Funding: European Commission.

OriģinālvalodaAngļu
Lapas (no-līdz)31-39
Lapu skaits9
ŽurnālsThe Lancet Infectious Diseases
Sējums14
Izdevuma numurs1
DOIs
Publikācijas statussPublicēts - janv. 2014
Ārēji publicētsJā

ANO IAM

Šis izpildes rezultāts palīdz sasniegt šādus ANO ilgtspējīgas attīstības mērķus (IAM)

  1. 3. IAM — Laba Veselība un Labbūtība
    3. IAM — Laba Veselība un Labbūtība

OECD Zinātnes nozare

  • 3. Medicīnas un veselības zinātnes

Nospiedums

Uzziniet vairāk par pētniecības tēmām “Interventions to reduce colonisation and transmission of antimicrobial-resistant bacteria in intensive care units: An interrupted time series study and cluster randomised trial”. Kopā tie veido unikālu nospiedumu.

Citēt šo